α1-Adrenoceptor-dependent vascular hypertrophy and remodeling in murine hypoxic pulmonary hypertension

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 292, Issue 5, 2007, Pages

  Faber, James E ^a,f   Szymeczek, Caroline L ^a   Cotecchia, Susanna ^b   Thomas, Steven A ^c   Tanoue, Akito ^d   Tsujimoto, Gozoh ^e   Zhang, Hua ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^e KYOTO UNIVERSITY   (Japan)

^f UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Adrenergic receptors; Hypoxia; Vascular smooth muscle

Indexed keywords

ADRENALIN; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1B ADRENERGIC RECEPTOR; ALPHA 1D ADRENERGIC RECEPTOR; CATECHOLAMINE; DOPAMINE BETA MONOOXYGENASE; NORADRENALIN; OXYGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTERY WALL; ARTICLE; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; HEART RIGHT VENTRICLE PRESSURE; HEART VENTRICLE HYPERTROPHY; HEMATOCRIT; KNOCKOUT MOUSE; LUNG BLOOD VESSEL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; WILD TYPE; ANIMAL; ANOXIA; C57BL MOUSE; HYPERTROPHY; METABOLISM; PATHOLOGY; PULMONARY ARTERY;

ANIMALS; ANOXIA; HYPERTENSION, PULMONARY; HYPERTROPHY; MALE; MICE; MICE, INBRED C57BL; NOREPINEPHRINE; PULMONARY ARTERY; RECEPTORS, ADRENERGIC, ALPHA-1;

EID: 34250828414     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00792.2006     Document Type: Article

References (43)

1. Bevan JA, Oriowo MA, Bevan RD. Physiological variation in α-adrenoreceptor-mediated arterial sensitivity: relation to agonist affinity. Science 234: 196-197, 1986.
2. Bleeke T, Zhang H, Madamanchi H, Patterson C, Faber JE. Catecholamine-induced vascular wall growth is dependent on generation of reactive oxygen species. Circ Res 94: 37-45, 2004.
3. Botney MD. Role of hemodynamics in pulmonary vascular remodeling. Am J Respir Crit Care Med 159: 361-364, 1999.
4. Budhiraja R, Tuder RM, Hassoun PM. Endothelial dysfunction in pulmonary hypertension. Circulation 109: 159-165, 2004.
5. Chalothorn D, Zhang H, Clayton JA, Thomas SA, Faber JE. Catecholamines augment collateral vessel growth and angiogenesis in hind limb ischemia. Am J Physiol Heart Circ Physiol 289: H947-H959, 2005.
6. Chien S, Usami S, Skalak R. Blood flow in small tubes. In: Handbook of Physiology. The Cardiovascular System. Microcirculation. Bethesda, MD: Am. Physiol. Soc., 1984, sect. 2, vol. IV, part 1, chapt. 6, p. 217-250.
7. De Caestecker M. Serotonin signaling in pulmonary hypertension. Circ Res 98: 1229-1231, 2006.
8. Deighan C, Methven L, Naghadeh MM, Wokoma A, Macmillan J, Daly CJ, Tanoue A, Tsujimoto G, McGrath JC. Insights into the functional roles of alpha(1)-adrenoceptor subtypes in mouse carotid arteries using knockout mice. Br J Pharmacol 144: 558-565, 2005.
9. 1B-adrenergic receptor gene promoter region and hypoxia regulatory elements in vascular smooth muscle. Proc Natl Acad Sci USA 94: 9487-9492, 1997.
10. 1- Adrenoceptor stimulation directly induces growth of the injured vascular wall in vivo. Am J Physiol Heart Circ Physiol 283: H1577-H1587, 2002.
11. Erami C, Zhang H, Tanoue A, Tsujimoto G, Thomas SA, Faber JE. Adrenergic catecholamine trophic activity contributes to flow-mediated arterial remodeling. Am J Physiol Heart Circ Physiol 289: H744-H753, 2005.
12. 1-adrenergic trophic activity in pulmonary artery of hypoxic pulmonary hypertensive rats. Am J Physiol Heart Circ Physiol 291: H2272-H2281, 2006.
13. Faber JE, Yang N, Xin X. Expression of α-adrenoceptor subtypes by smooth muscle cells and adventitial fibroblasts in rat aorta and in cell culture. J Pharmacol Exp Ther 298: 441-452, 2001.
14. Farber HW, Loscalzo J. Pulmonary arterial hypertension. N Engl J Med 351: 1655-1665, 2004.
15. Fried R, Meyrick B, Rabinovitch M, Reid L. Polycythemia and the acute hypoxic response in awake rats following chronic hypoxia. J Appl Physiol 55: 1167-1172, 1983.
16. Hosoda C, Koshimizu TA, Tanoue A, Nasa Y, Oikawa R, Tomabechi T, Fukuda S, Shinoura H, Oshikawa S, Takeo S, Kitamura T, Cotecchia S, Tsujimoto G. Two alpha1-adrenergic receptor subtypes regulating the vasopressor response have differential roles in blood pressure regulation. Mol Pharmacol 67: 912-922, 2005.
17. Humbert M, Morrell NW, Archer SL, Stenmark KR, MacLean MR, Lang IM, Christman BW, Weir EK, Eickelberg O, Voelkel NF, Rabinovitch M. Cellular and molecular pathobiology of pulmonary arterial hypetension. J Am Coll Cardiol 43: 13S-24S, 2004.
18. Irodova NL, Krashnikova TL, Masenko VP, Kochetov AG, Lazutkina VK, Chazova IE. Catecholamine levels in plasma and beta2-adrenoreceptor- dependent synthesis of cAMP in lymphocytes of patients with primary pulmonary hypertension. Ter Arkh 74: 55-59, 2002.
19. James MF, Hickman R, Janicki P, Mets B, Fourie J. Early effects of total hepatectomy on haemodynamic state and organ uptake of catecholamines in the pig. Br J Anaesth 76: 713-720, 1996.
20. Janssens SP, Thompson BT, Spence CR, Hales CA. Polycythemia and vascular remodeling in chronic hypoxic pulmonary hypertension in guinea pigs. J Appl Physiol 71: 2218-2223, 1991.
21. Jernigan NL, Walker BR, Resta TC. Endothelium-derived reactive oxygen species and endothelin-1 attenuate NO-dependent pulmonary vasodilation following chronic hypoxia. Am J Physiol Lung Cell Mol Physiol 287: L801-L808, 2004.
22. Launay JM, Herve P, Peoc'h K, Tournois C, Callebert J, Nebigil CG, Etienne N, Drouet L, Humbert M, Simonneau G, Maroteaux L. Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension. Nat Med 8: 1129-1135, 2002.
23. Lowe FC. Role of the newer alpha adrenergic-receptor antagonists in the treatment of benign prostatic hyperplasia-related lower urinary tract symptoms. Clin Ther 26: 1701-1713, 2004.
24. Naeye RL. Polycythemia and hypoxia. Individual effects on heart and pulmonary arteries. Am J Pathol 50: 1027-1033, 1967.
25. 1- Adrenoceptor subtypes mediating noradrenaline-induced contraction of pulmonary artery from pulmonary hypertensive rats. Eur J Pharmacol 482: 255-263, 2003.
26. Pollock DM. Endothelin, angiotensin, and oxidative stress in hypertension. Hypertension 45: 477-480, 2005.
27. Powell PP, Klagsbrun M, Abraham JA, Jones RC. Eosinophils expressing heparin-binding EGF-like growth factor mRNA localize around lung microvessels in pulmonary hypertension. Am J Pathol 143: 784-793, 1993.
28. Presberg KW, Dincer HE. Pathophysiology of pulmonary hypertension due to lung disease. Curr Opin Pulm Med 9: 131-138, 2003.
29. Rabinovitch M. Diseases of the pulmonary vasculature. In: Comprehensive Cardiovascular Medicine, edited by Topol EJ. Philadelphia, PA: Lippencott-Raven, 1998, p. 3001-3029.
30. Rokosh DG, Simpson PC. Knockout of the α1A/C-adrenergic receptor subtype: the α1A/C is expressed in resistance arteries and is required to maintain arterial blood pressure. Proc Natl Acad Sci USA 99: 9474-9479, 2002.
31. 1-Adrenergic hypothesis for pulmonary hypertension. Chest 115: 1708-1719, 1999.
32. Salvi SS. Liver disease and pulmonary hypertension. Gut 47: 595, 2000.
33. Stenmark KR, Mecham RP. Cellular and molecular mechanisms of pulmonary vascular remodeling. Annu Rev Physiol 59: 89-144, 1997.
34. Swoap SJ, Weinshenker D, Palmiter RD, Garber G. Dbh(-/-) mice are hypotensive, have altered circadian rhythms, and have abnormal responses to dieting and stress. Am J Physiol Regul Integr Comp Physiol 286: R108-R113, 2004.
35. Velez-Roa S, Ciarka A, Najem B, Vachiery JL, Naeije T, van de Borne P. Increased sympathetic nerve activity in pulmonary artery hypertension. Circulation 110: 1308-1312, 2004.
36. Vecchione C, Fratta L, Rizzoni D, Notte A, Poulet R, Porteri E, Frati G, Guelfi D, Trimarco V, Mulvany MJ, Agabiti-Rosei E, Trimarco B, Cotecchia S, Lembo G. Cardiovascular influences of alpha1b-adrenergic receptor defect in mice. Circulation 105: 1700-1707, 2002.
37. Walker BR, Resta TC, Nelin LD. Nitric oxide-dependent pulmonary vasodilation in polycythemic rats. Am J Physiol Heart Circ Physiol 279: H2382-H2389, 2000.
38. 1-adrenergic receptor stimulation in left versus right ventricular myocardium. Am J Physiol Heart Circ Physiol 291: H2013-H2017, 2006.
39. 1-adrenoceptor subtypes. Radioligand binding studies. J Pharmacol Exp Ther 286: 841-847, 1998.
40. 1-adrenoceptor subtypes. Circ Res 89: 815-822, 2002.
41. Zhang H, Facemire C, Banes AJ, Faber JE. Norepinephrine stimulates migration of vascular smooth muscle cells and adventitial fibroblasts in vitro: mediation by different adrenoceptor subtypes. Am J Physiol Heart Circ Physiol 282: H2364-H2370, 2002.
42. Zhang H, Chalothorn D, Jackson L, Lee DC, Faber JE. Transactivation of epidermal growth factor receptor mediates catecholamine-induced growth of vascular smooth muscle. Circ Res 95: 989-997, 2004.
43. 1- adrenoceptors demonstrates involvement of catecholamines in vascular remodeling. Am J Physiol Heart Circ Physiol 287: H2106-H2114, 2004.